343 related articles for article (PubMed ID: 27837408)
1. Humanizing glycosylation pathways in eukaryotic expression systems.
Khan AH; Bayat H; Rajabibazl M; Sabri S; Rahimpour A
World J Microbiol Biotechnol; 2017 Jan; 33(1):4. PubMed ID: 27837408
[TBL] [Abstract][Full Text] [Related]
2. Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.
Niimi T
Methods Mol Biol; 2012; 824():307-15. PubMed ID: 22160905
[TBL] [Abstract][Full Text] [Related]
3. Strategies for humanizing glycosylation pathways and producing recombinant glycoproteins in microbial expression systems.
Khan AH; Noordin R
Biotechnol Prog; 2019 Mar; 35(2):e2752. PubMed ID: 30457225
[TBL] [Abstract][Full Text] [Related]
4. Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins.
Brooks SA
Expert Rev Proteomics; 2006 Jun; 3(3):345-59. PubMed ID: 16771706
[TBL] [Abstract][Full Text] [Related]
5. Potential application of Leishmania tarentolae as an alternative platform for antibody expression.
Lai JY; Klatt S; Lim TS
Crit Rev Biotechnol; 2019 May; 39(3):380-394. PubMed ID: 30720351
[TBL] [Abstract][Full Text] [Related]
6. The humanization of N-glycosylation pathways in yeast.
Wildt S; Gerngross TU
Nat Rev Microbiol; 2005 Feb; 3(2):119-28. PubMed ID: 15685223
[TBL] [Abstract][Full Text] [Related]
7. N-glycosylation engineering of biopharmaceutical expression systems.
Jacobs PP; Callewaert N
Curr Mol Med; 2009 Sep; 9(7):774-800. PubMed ID: 19860659
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation control technologies for recombinant therapeutic proteins.
Gupta SK; Shukla P
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
[TBL] [Abstract][Full Text] [Related]
9. Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania tarentolae.
Soleimani M; Mahboudi F; Davoudi N; Amanzadeh A; Azizi M; Adeli A; Rastegar H; Barkhordari F; Mohajer-Maghari B
Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):55-61. PubMed ID: 17371294
[TBL] [Abstract][Full Text] [Related]
10. Main Strategies of Plant Expression System Glycoengineering for Producing Humanized Recombinant Pharmaceutical Proteins.
Rozov SM; Permyakova NV; Deineko EV
Biochemistry (Mosc); 2018 Mar; 83(3):215-232. PubMed ID: 29625542
[TBL] [Abstract][Full Text] [Related]
11. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi.
Gerngross TU
Nat Biotechnol; 2004 Nov; 22(11):1409-14. PubMed ID: 15529166
[TBL] [Abstract][Full Text] [Related]
12. Recombinant glycoprotein production in human cell lines.
Swiech K; de Freitas MC; Covas DT; Picanço-Castro V
Methods Mol Biol; 2015; 1258():223-40. PubMed ID: 25447867
[TBL] [Abstract][Full Text] [Related]
13. Recombinant protein expression in Leishmania tarentolae.
Basile G; Peticca M
Mol Biotechnol; 2009 Nov; 43(3):273-8. PubMed ID: 19779853
[TBL] [Abstract][Full Text] [Related]
14. Leishmania tarentolae for the Production of Multi-subunit Complexes.
Niimi T
Adv Exp Med Biol; 2016; 896():155-65. PubMed ID: 27165324
[TBL] [Abstract][Full Text] [Related]
15. N-Glycosylation engineering of lepidopteran insect cells by the introduction of the beta1,4-N-acetylglucosaminyltransferase III gene.
Okada T; Ihara H; Ito R; Nakano M; Matsumoto K; Yamaguchi Y; Taniguchi N; Ikeda Y
Glycobiology; 2010 Sep; 20(9):1147-59. PubMed ID: 20554946
[TBL] [Abstract][Full Text] [Related]
16. Production of recombinant proteins by microbes and higher organisms.
Demain AL; Vaishnav P
Biotechnol Adv; 2009; 27(3):297-306. PubMed ID: 19500547
[TBL] [Abstract][Full Text] [Related]
17. Engineering of glycosylation in yeast and other fungi: current state and perspectives.
De Pourcq K; De Schutter K; Callewaert N
Appl Microbiol Biotechnol; 2010 Aug; 87(5):1617-31. PubMed ID: 20585772
[TBL] [Abstract][Full Text] [Related]
18. Expression of multisubunit proteins in Leishmania tarentolae.
Sugino M; Niimi T
Methods Mol Biol; 2012; 824():317-25. PubMed ID: 22160906
[TBL] [Abstract][Full Text] [Related]
19. Glycan-Based Cell Targeting To Modulate Immune Responses.
Johannssen T; Lepenies B
Trends Biotechnol; 2017 Apr; 35(4):334-346. PubMed ID: 28277249
[TBL] [Abstract][Full Text] [Related]
20. Emerging technologies for making glycan-defined glycoproteins.
Wang LX; Lomino JV
ACS Chem Biol; 2012 Jan; 7(1):110-22. PubMed ID: 22141574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
